[go: up one dir, main page]

WO2022032360A1 - Composition based on plant oils to replace lanolin - Google Patents

Composition based on plant oils to replace lanolin Download PDF

Info

Publication number
WO2022032360A1
WO2022032360A1 PCT/BR2020/050313 BR2020050313W WO2022032360A1 WO 2022032360 A1 WO2022032360 A1 WO 2022032360A1 BR 2020050313 W BR2020050313 W BR 2020050313W WO 2022032360 A1 WO2022032360 A1 WO 2022032360A1
Authority
WO
WIPO (PCT)
Prior art keywords
lanolin
oil
composition based
mass
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BR2020/050313
Other languages
French (fr)
Portuguese (pt)
Inventor
Angel DACHS YAGODA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maian Industria De Produtos Quimicos Ltda
Original Assignee
Maian Industria De Produtos Quimicos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maian Industria De Produtos Quimicos Ltda filed Critical Maian Industria De Produtos Quimicos Ltda
Priority to PCT/BR2020/050313 priority Critical patent/WO2022032360A1/en
Priority to BR112023002610A priority patent/BR112023002610A2/en
Publication of WO2022032360A1 publication Critical patent/WO2022032360A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention refers to a composition based on vegetable oils with application in the cosmetic or pharmaceutical industry, as a substitute for lanolin. Particularly in the pharmaceutical industry, the composition has healing properties.
  • Lanolin is the fat in wool that is manufactured from the sebaceous secretions of sheep's fat. It is a mixture of sterols and long-chain fatty alcohols. This mixture sometimes contains other substances (nickel, chromium, copper, etc.) in the form of traces.
  • Lanolin is a natural product obtained from raw wool wax generated by textile improvers as a by-product of the process. During processing, the wool is washed with a mixture of soaps and detergents, generating a mixture of water, soaps and various types of impregnated impurities.
  • Lanolin is a wax consisting of a mixture of high molecular weight esters. These esters that compose it are the result of countless combinations between different types of alcohols and acids, making lanolin a unique material.
  • Lanolin is composed of esters whose acid fraction has a carbon chain ranging from C7 to C40 and the alcoholic fraction from C14 to C36. Therefore, the final combination of esters is very large, but the most important components are the hydroxy-esters from the combination of fatty acids with diols and sterols or fatty alcohols with hydroxy acids.
  • Lanolin is a chemical specialty with high added value and due to the volume demanded by the cosmetic and pharmaceutical industries, there is a need for many flocks of sheep to meet this demand. [009] Lanolin is a yellowish to gray semi-solid containing 25 to 30% water in its hydrated form and a yellow-brown semi-solid in its anhydrous form. Lanolin contains cholesteryl esters of higher fatty acids.
  • lanolin Due to its emollient, moisturizing, emulsifying properties and its ability to absorb water, lanolin is used as a component of pharmaceutical products, leather finishing compositions, soaps and detergents, face creams, facial tissues, hair compositions, suntan preparations and the like.
  • EP 0051148 teaches lanolin substitute product comprising short chain fatty acids and coconut fatty acid.
  • US 2005233015 A teaches lanolin substitute based on shea butter.
  • WO 2004065533 teaches lanolin substitutes that are obtained from saturated and/or unsaturated fatty acids, or their esters, or hydrocarbons, and may contain vegetable oils, which are subjected to heat treatment from 100 °C to 400 ° C, particularly between 230°C to 350°C.
  • DE 10143948 teaches a substitute product for lanolin based on polyisobutene, which may contain vegetable oils.
  • the present invention deals with a substitute product for lanolin that has advantages over products known to man in the art.
  • composition based on vegetable oils to replace lanolin was developed, which surprisingly has healing properties.
  • the composition comprises coconut oil, sunflower oil and soy lecithin.
  • composition based on vegetable oil substitutes for lanolin comprises:
  • coconut oil, coconut oil or coconut butter is a vegetable oil that contains about 90% of fatty acids extracted by pressing the pulp or core of coconuts (Cocos nucifera).
  • coconut fatty acid diethanolamides lauric alcohol derivatives such as sodium lauryl sulfate, corrosion inhibitors, sulfonated oil and several other products in the raw material industry for cosmetics.
  • _Coconut oil can be extracted through “dry” or “wet” processing. Dry processing requires the dough to be extracted from the shell and dried using fire, sunlight, or an oven to create copra. Copra is processed or dissolved with solvents, producing coconut oil and a pulp with high protein and fiber content. Pulp is generally used to feed ruminants, as it is not of sufficient quality by industrial standards. There is no process to extract the protein from the pulp.
  • the "wet” process uses raw coconut instead of copra, and the proteins present in the coconut create an emulsion of water and oil. The emulsion is then broken down by prolonged boiling, centrifugation or pretreatments including cold, heat, acids, salts, enzymes, electrolysis, shock waves, steam distillation, or some combination.
  • Another method for extracting coconut oil involves the enzymatic action of alpha-amylase, polygalacturonase and proteases in a diluted coconut paste.
  • Refined oil can be further processed into partially hydrogenated oil or hydrogenated oil, to increase its melting point.
  • virgin and refined oils melt at a temperature of 24°C
  • foods containing coconut oils tend to melt in hot climates. Therefore, a higher melting point is desirable in these climates.
  • the melting point of hydrogenated coconut oil varies between 36°C and 40°C.
  • the composition of refined coconut oil comprises C6 - C20 fatty acids, such as: caproic acid, caprylic acid, lauric acid, myristic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid and arachidic acid.
  • C6 - C20 fatty acids such as: caproic acid, caprylic acid, lauric acid, myristic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid and arachidic acid.
  • refined coconut oil extracted from the almond fruit of the oil palm Elaeis guineensis and subjected to the refining process has the fatty acid composition indicated in Table 1 below:
  • coconut fat is composed of lauric acid. In the human body, it is transformed into monolaurin, a monoglyceride of antibacterial, antiviral and antiprotozoal action, used by the body to destroy the lipid layer of various microorganisms.
  • the coconut oil according to the invention must have a maximum acidity Mg KOH/g of 0.1% measured by the AOCS Method Ca 5a-40.
  • the present invention deals with a composition that comprises, in relation to its total mass, from 50% to 85% by weight of coconut oil.
  • Refined coconut oil is preferably used.
  • composition also comprises in relation to its total mass from 8% to 26% of sunflower oil.
  • Sunflower oil is extracted from the seed of the Heüanthus annuus plant.
  • the sunflower Heüanthus annuus is an annual plant of the Asteraceae family, genus Heliantheae. The name is derived from the shape of its inflorescence.
  • Sunflower oil comprises C12 - C22 fatty acids such as: lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid (Omega 9), linoleic acid (Omega 6), linolenic acid (Omega 3), arachidic acid, eicosenoic acid, behenic acid, erucic acid and lignoceric acid, as indicated in Table 2 below:
  • sunflower oil is essentially made up of triacylglycerols (98 to 99%). It has a high content of unsaturated acids (about 83%), but a low content of linolenic acid ( ⁇ 0.2%). Sunflower oil is essentially rich in essential fatty acid (EFA) or linoleic acid.
  • EFA essential fatty acid
  • the sunflower oil according to the invention must have a maximum acidity Mg KOH/g of 2 measured by the AOCS Method Ca 5a-40 and comprise a C18:l grease chain from 75% to 90.7%.
  • composition according to the invention comprises, in relation to the total mass of the composition, 5% to 22% by mass of soy lecithin.
  • Lecithin is a phospholipid found naturally in foods of animal and vegetable origin, with egg yolk, soy and wheat germ being the main sources.
  • the main phospholipids present in marketed lecithin are phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and phosphatidic acid (generally abbreviated as PC, PI, PE and PA, respectively).
  • the lecithin can be enzymatically hydrolyzed.
  • a portion of the phospholipids have a fatty acid removed by the action of a phospholipase.
  • Such phospholipids are referred to as lysophospholipids.
  • the most commonly used phospholipase for this purpose is called phospholipase A2, which removes the fatty acid at the sn-2 position.
  • Lecithins can also be modified by a process called fractionation, which consists of mixing the oil in an alcohol (usually ethanol). Some phospholipids have good solubility in ethanol (e.g. phosphatidylcholine), whereas other phospholipids are shown to be insoluble in the same solvent. The ethanol solution is then decanted and subjected to solvent evaporation in order to obtain a phosphatidylcholine-enriched lecithin fraction.
  • fractionation consists of mixing the oil in an alcohol (usually ethanol).
  • Some phospholipids have good solubility in ethanol (e.g. phosphatidylcholine), whereas other phospholipids are shown to be insoluble in the same solvent.
  • the ethanol solution is then decanted and subjected to solvent evaporation in order to obtain a phosphatidylcholine-enriched lecithin fraction.
  • the soy lecithin used according to the invention must have an acidity Mg KOH/g of at most 2 measured by the AOCS Ja 6-55 method.
  • the composition comprises, by mass in relation to the total mass of the composition, the following components:
  • the composition comprises, by mass in relation to the total mass of the composition, the following components:
  • the lanolin substitute composition according to the invention has healing properties and can be used in the pharmaceutical industry in products that require this property, such as ointments, plasters, etc.
  • the method of obtaining the composition involves the following steps:
  • the method of obtaining the composition involves the following steps:
  • a lanolin substitute composition according to the invention was reproduced comprising the components as indicated in Table 3 below:
  • composition indicated in example 1 was obtained through a protocol that involved the following steps:
  • the mixture was heated to a temperature of 50 °C, until the components became liquid (the temperature was not increased further as the carbon chains of the components could break);
  • human keratinocyte cells from the epidermis were used, maintained in culture with DMEM (Dulbecco's Modified Eagle's Medium) with the addition of supplements, in an oven at 37°C and 5% CO2 and manipulated inside a laminar flow hood. In passage 03 after thawing, the cells were distributed in 35mm plates.
  • DMEM Dulbecco's Modified Eagle's Medium
  • NV.12.02 showed complete closure of the sham wound, while the control group needed 48 hours to close the wound completely.
  • Figure 1 attached, brings the representative images of the respective groups and times.
  • Figure 2 and Table 4 demonstrate the percentage of wound closure according to time between groups, with 0% being considered at time 0h and 100% when it was not possible to identify the bottom of the plaque in the image.
  • Example 4 A lanolin substitute composition according to the invention was reproduced comprising the components as indicated in Table 5 below:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition based on plant oils for use in the cosmetic or pharmaceutical industry to replace lanolin. The composition has cicatrizing properties, which is noteworthy when used in the pharmaceutical industry, The composition based on plant oils replaces lanolin and includes the following components: (a) coconut oil, (b) sunflower oil, and (c) soy lecithin.

Description

COMPOSIÇÃO A BASE DE ÓLEOS VEGETAIS SUBSTITUTA DE LANOLINA COMPOSITION BASED ON VEGETABLE OILS REPLACEMENT FOR LANOLIN

Campo da Invenção Field of Invention

[001] A presente invenção refere a uma composição a base de óleos vegetais com aplicação na indústria cosmética ou farmacêutica, como substituinte de lanolina. Particularmente na indústria farmacêutica a composição apresenta propriedades cicatriza ntes. [001] The present invention refers to a composition based on vegetable oils with application in the cosmetic or pharmaceutical industry, as a substitute for lanolin. Particularly in the pharmaceutical industry, the composition has healing properties.

Antecedentes da Invenção Background of the Invention

[002] A lanolina é a gordura da lã que é fabricada a partir das secreções sebáceas da gordura de ovelha. Trata-se de uma mistura de esteróis e álcoois graxos de cadeia longa. Essa mistura às vezes contém outras substâncias (níquel, cromo, cobre, etc) na forma de traços. [002] Lanolin is the fat in wool that is manufactured from the sebaceous secretions of sheep's fat. It is a mixture of sterols and long-chain fatty alcohols. This mixture sometimes contains other substances (nickel, chromium, copper, etc.) in the form of traces.

[003] A lanolina é um produto natural obtido a partir da cera de lã bruta gerada pelos beneficiadores têxteis como um sub produto do processo. Durante o beneficiamento, a lã é lavada com uma mistura de sabões e detergentes gerando uma mistura de água, sabões e vários tipos de impurezas impregnadas. [003] Lanolin is a natural product obtained from raw wool wax generated by textile improvers as a by-product of the process. During processing, the wool is washed with a mixture of soaps and detergents, generating a mixture of water, soaps and various types of impregnated impurities.

[004] Normalmente pode-se obter por volta de 10 a 15% de gordura de lã neste tipo de processo. A lanolina é, então, obtida através de um sofisticado processo de refinação de cera da lã bruta. [004] Normally, around 10 to 15% of wool fat can be obtained in this type of process. Lanolin is then obtained through a sophisticated process of wax refining the raw wool.

[005] A lanolina é uma cera constituída de uma mistura de ésteres de alto peso molecular. Esses ésteres que a compõem são resultados de inúmeras combinações entre diversos tipos de álcoois e ácidos, fazendo com que a lanolina seja um material único. [005] Lanolin is a wax consisting of a mixture of high molecular weight esters. These esters that compose it are the result of countless combinations between different types of alcohols and acids, making lanolin a unique material.

[006] A lanolina é composta por ésteres cuja fração ácida tem cadeia carbônica variando de C7 a C40 e a fração alcoólica de C14 a C36. Portanto, a combinação final de ésteres é muito grande, mas os componentes mais importantes são os hidroxi-ésteres provenientes da combinação de ácidos graxos com dióis e esteróis ou de álcoois graxos com hidroxi- ácidos. [006] Lanolin is composed of esters whose acid fraction has a carbon chain ranging from C7 to C40 and the alcoholic fraction from C14 to C36. Therefore, the final combination of esters is very large, but the most important components are the hydroxy-esters from the combination of fatty acids with diols and sterols or fatty alcohols with hydroxy acids.

[007] Esses hidroxi-ésteres são os grandes responsáveis pela capacidade de absorção de água da Lanolina, uma das suas principais características, responsável até hoje pela sua utilização e importância. [007] These hydroxy-esters are largely responsible for the water absorption capacity of Lanolin, one of its main characteristics, responsible until today for its use and importance.

[008] A lanolina é uma especialidade química de alto valor agregado e que devido ao volume demandado pelas indústrias cosmética e farmacêutica há necessidade de muitos rebanhos de ovelhas para atender tal demanda. [009] A lanolina é um semi-sólido amarelado a cinza contendo 25 a 30% de água em sua forma hidratada e um semi-sólido amarelo-acastanhado em sua forma anidra. A lanolina contém ésteres de colesterol de ácidos graxos mais elevados. [008] Lanolin is a chemical specialty with high added value and due to the volume demanded by the cosmetic and pharmaceutical industries, there is a need for many flocks of sheep to meet this demand. [009] Lanolin is a yellowish to gray semi-solid containing 25 to 30% water in its hydrated form and a yellow-brown semi-solid in its anhydrous form. Lanolin contains cholesteryl esters of higher fatty acids.

[0010] Devido às suas propriedades emolientes, hidratantes, emulsificantes e sua capacidade de absorção de água lanolina é usada como componente de produtos farmacêuticos, composições para acabamento de couro, sabões e detergentes, cremes para o rosto, tecidos faciais, composições para cabelos, preparações para bronzear e similares. [0010] Due to its emollient, moisturizing, emulsifying properties and its ability to absorb water, lanolin is used as a component of pharmaceutical products, leather finishing compositions, soaps and detergents, face creams, facial tissues, hair compositions, suntan preparations and the like.

[0011] Apesar de todas essas propriedades a origem animal da lanolina é cada vez menos satisfatória para o consumidor, incomodada pelo tremor epizoótico. Reações alérgicas decorrentes de resíduos de pesticidas, odor forte, composição variável, falta de confiabilidade no fornecimento, etc, são fatores adicionais que levaram os cientistas a procurar substitutos da lanolina. [0011] Despite all these properties the animal origin of lanolin is less and less satisfactory for the consumer, bothered by scrapie. Allergic reactions stemming from pesticide residues, strong odor, variable composition, unreliable supply, etc. are additional factors that have led scientists to look for lanolin substitutes.

[0012] As tentativas de substituição de lanolina por produtos oleoquímicos são numerosas. [0012] Attempts to replace lanolin with oleochemicals are numerous.

[0013] Até agora, os substitutos propostos não oferecem satisfação total por causa das propriedades, da complexidade de sua composição, de certas características físico- químicas elevadas, como o índice de acidez, e/ou de seus custos de fabricação. [0013] So far, the proposed substitutes do not offer total satisfaction because of the properties, the complexity of their composition, certain high physicochemical characteristics, such as the acidity index, and/or their manufacturing costs.

[0014] O documento EP 0051148 ensina produto substituto de lanolina compreendendo ácidos graxos de cadeia curta e ácido graxo de coco. [0014] EP 0051148 teaches lanolin substitute product comprising short chain fatty acids and coconut fatty acid.

[0015] O documento US 2005233015 A ensina substituto de lanolina a base de manteiga de karité. [0015] US 2005233015 A teaches lanolin substitute based on shea butter.

[0016] O documento WO 2004065533 ensina substituto de lanolina que são obtidos a partir de ácidos graxos saturados e/ou insaturados, ou seus ésteres, ou hidrocarbonetos, podendo conter óleos vegetais, que são submetidos a tratamento térmico de 100 °C a 400 °C, particularmente entre 230 °C a 350 °C. [0016] WO 2004065533 teaches lanolin substitutes that are obtained from saturated and/or unsaturated fatty acids, or their esters, or hydrocarbons, and may contain vegetable oils, which are subjected to heat treatment from 100 °C to 400 ° C, particularly between 230°C to 350°C.

[0017] O documento DE 10143948 ensina produto substituto para lanolina a base de poli- isobuteno, podendo conter óleos vegetais. [0017] DE 10143948 teaches a substitute product for lanolin based on polyisobutene, which may contain vegetable oils.

[0018] A presente invenção trata de um produto substituto para lanolina que apresenta vantagens em relação aos produtos conhecidos do homem da técnica. [0018] The present invention deals with a substitute product for lanolin that has advantages over products known to man in the art.

Objetivos da Invenção Objectives of the Invention

[0019] Foi desenvolvida uma composição substituta de lanolina na indústria farmacêutico ou cosmética, que apresentasse: [0019] A substitute composition for lanolin was developed in the pharmaceutical industry or cosmetic, which presented:

- preço final atraente; - attractive final price;

- um produto sustentável; - a sustainable product;

- empregasse matéria-prima disponível no mercado e não tóxica; - use raw material available on the market and non-toxic;

- empregasse um processo de obtenção de baixo consumo de energia e sem produção de efluentes. - employ a process to obtain low energy consumption and without the production of effluents.

Resumo da Invenção Summary of the Invention

[0020] Foi desenvolvida uma composição a base de óleos vegetais substituta de lanolina que surpreendentemente apresenta propriedade cicatrizante. A composição compreende óleo de coco, óleo de girassol e lecitina de soja. [0020] A composition based on vegetable oils to replace lanolin was developed, which surprisingly has healing properties. The composition comprises coconut oil, sunflower oil and soy lecithin.

Breve Descrição das Figuras Brief Description of Figures

- A Figura 1 ilustra as imagens representativas dos respectivos grupos e tempos. - Figure 1 illustrates the representative images of the respective groups and times.

- A Figura 2 ilustra a porcentagem de fechamento da ferida conforme o tempo, entre os grupos. - Figure 2 illustrates the percentage of wound closure over time, between groups.

Descrição Detalhada da Invenção Detailed Description of the Invention

[0021] A presente invenção será descrita agora de forma mais completa. A composição a base de óleos vegetais substituta de lanolina segundo a invenção compreende: [0021] The present invention will now be described more fully. The composition based on vegetable oil substitutes for lanolin according to the invention comprises:

(a) óleo de coco; (a) coconut oil;

(b) óleo de girassol; e (b) sunflower oil; and

(c) lecitina de soja. (c) soy lecithin.

[0022] O óleo de coco, azeite de coco ou manteiga de coco é um óleo vegetal que contém cerca de 90% de ácidos graxos extraídos mediante prensagem da polpa ou cerne dos cocos (Cocos nucifera). [0022] Coconut oil, coconut oil or coconut butter is a vegetable oil that contains about 90% of fatty acids extracted by pressing the pulp or core of coconuts (Cocos nucifera).

[0023] Ele é muito empregado na indústria dos cosméticos (para elaboração de sabões e cremes). [0023] It is widely used in the cosmetics industry (for making soaps and creams).

[0024] É matéria-prima para a produção de dietanolamidas de ácido graxo de coco, derivados do álcool láurico como os lauril sulfato de sódio, inibidores de corrosão, óleo sulfonados e diversos outros produtos na indústria de matérias primas para cosméticos. [0024] It is raw material for the production of coconut fatty acid diethanolamides, lauric alcohol derivatives such as sodium lauryl sulfate, corrosion inhibitors, sulfonated oil and several other products in the raw material industry for cosmetics.

[0025] Óleo virgem [0025] Virgin oil

[0026]_0 óleo de coco pode ser extraído através de processamento "seco" ou "molhado". O processamento a seco requer que a massa seja extraída da casca e seca usando fogo, luz solar, ou forno para criar copra. A copra é processada ou dissolvida com solventes, produzindo óleo de coco e uma polpa com alto teor proteico e de fibras. A polpa geralmente é utilizada para alimentar ruminantes, visto que ela não tem qualidade suficiente para os padrões industriais. Não há nenhum processo para extrair a proteína da polpa. [0026]_Coconut oil can be extracted through "dry" or "wet" processing. Dry processing requires the dough to be extracted from the shell and dried using fire, sunlight, or an oven to create copra. Copra is processed or dissolved with solvents, producing coconut oil and a pulp with high protein and fiber content. Pulp is generally used to feed ruminants, as it is not of sufficient quality by industrial standards. There is no process to extract the protein from the pulp.

[0027] O processo "molhado" usa coco cru ao invés de copra, e as proteínas presentes no coco criam uma emulsão de água e óleo. Quebra-se então a emulsão por fervura prolongada, centrifugação ou pré-tratamentos incluindo frio, calor, ácidos, sais, enzimas, eletrólise, ondas de choque, destilação a vapor, ou alguma combinação. [0027] The "wet" process uses raw coconut instead of copra, and the proteins present in the coconut create an emulsion of water and oil. The emulsion is then broken down by prolonged boiling, centrifugation or pretreatments including cold, heat, acids, salts, enzymes, electrolysis, shock waves, steam distillation, or some combination.

[0028] Óleo refinado [0028] Refined oil

[0029]_0 óleo refinado geralmente é feito a partir de grãos de coco secos, que são pressionados em uma prensa hidráulica aquecida para extrair o óleo. Isto produz praticamente todo o óleo presente, representando mais de 60% do peso seco do coco. Este óleo de coco "bruto" não é apropriado para o consumo porque contém contaminantes e deve ser refinado com mais aquecimento e filtragem. [0029]_ Refined oil is usually made from dried coconut kernels, which are pressed in a heated hydraulic press to extract the oil. This produces virtually all of the oil present, representing more than 60% of the coconut's dry weight. This "crude" coconut oil is not suitable for consumption because it contains contaminants and must be refined with further heating and filtration.

[0030] Um outro método para a extração de óleo de coco envolve a ação enzimática da alfa-amilase, poligalacturonase e proteases em uma pasta de coco diluída. [0030] Another method for extracting coconut oil involves the enzymatic action of alpha-amylase, polygalacturonase and proteases in a diluted coconut paste.

[0031] Hidroaenacão [0031] Hydroaenacao

[0032] O óleo refinado pode ser processado ainda mais em óleo parcialmente hidrogenado ou óleo hidrogenado, para aumentar seu ponto de fusão. Como óleos virgem e refinado derretem a uma temperatura de 24°C, alimentos contendo óleos de coco tendem a derreter em climas quentes. Por isso, um maior ponto de fusão é desejável nesses climas. O ponto de fusão do óleo de coco hidrogenado varia entre 36°C e 40°C. [0032] Refined oil can be further processed into partially hydrogenated oil or hydrogenated oil, to increase its melting point. As virgin and refined oils melt at a temperature of 24°C, foods containing coconut oils tend to melt in hot climates. Therefore, a higher melting point is desirable in these climates. The melting point of hydrogenated coconut oil varies between 36°C and 40°C.

[0033] A composição do óleo de coco refinado compreende ácidos graxos C6 - C20, tais como: ácido capróico, ácido caprílico, ácido láurico, ácido mirístico, ácido palmitoleico, ácido esteárico, oleico, ácido linoleico e ácido araquídico. [0033] The composition of refined coconut oil comprises C6 - C20 fatty acids, such as: caproic acid, caprylic acid, lauric acid, myristic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid and arachidic acid.

[0034] Por exemplo o óleo de coco refinado extraído da amêndoa do fruto da palmeira oleaginosa Elaeis guineensis e submetido ao processo de refino, apresenta a composição de ácidos graxos indicados na Tabela 1 abaixo:

Figure imgf000006_0001
Figure imgf000007_0001
[0034] For example, refined coconut oil extracted from the almond fruit of the oil palm Elaeis guineensis and subjected to the refining process, has the fatty acid composition indicated in Table 1 below:
Figure imgf000006_0001
Figure imgf000007_0001

TABELA 1 TABLE 1

[0035] Cerca de 40% da gordura do coco é composta pelo ácido láurico. No corpo humano, se transforma em monolaurina, um monoglicerídeo de ação antibacteriana, antiviral e antiprotozoária, usado pelo organismo para destruir a capa lipídica de vários microorganismos. [0035] About 40% of coconut fat is composed of lauric acid. In the human body, it is transformed into monolaurin, a monoglyceride of antibacterial, antiviral and antiprotozoal action, used by the body to destroy the lipid layer of various microorganisms.

[0036] O óleo de coco segundo a invenção deve apresentar uma acidez Mg KOH/g máxima de 0,1 % medida pelo Método AOCS Ca 5a-40. [0036] The coconut oil according to the invention must have a maximum acidity Mg KOH/g of 0.1% measured by the AOCS Method Ca 5a-40.

[0037] A presente invenção trata de composição que compreende em relação à sua massa total de 50 % a 85 % em peso de óleo de coco. Preferencialmente emprega-se óleo de coco refinado. [0037] The present invention deals with a composition that comprises, in relation to its total mass, from 50% to 85% by weight of coconut oil. Refined coconut oil is preferably used.

[0038] A composição também compreende em relação à sua massa total de 8% a 26% de óleo de girassol. [0038] The composition also comprises in relation to its total mass from 8% to 26% of sunflower oil.

[0039] O óleo de girassol é extraído da semente da planta Heüanthus annuus. [0039] Sunflower oil is extracted from the seed of the Heüanthus annuus plant.

[0040] É usado em cosméticos e devido a sua grande concentração de vitamina E, é recomendado para usar na pele (uso tópico) para proteção e fortalecimento. [0040] It is used in cosmetics and due to its high concentration of vitamin E, it is recommended for use on the skin (topical use) for protection and strengthening.

[0041] O girassol Heüanthus annuus é uma planta anual da família das Asteraceae, gênero Heliantheae. O nome é derivado do formato de sua inflorescência. [0041] The sunflower Heüanthus annuus is an annual plant of the Asteraceae family, genus Heliantheae. The name is derived from the shape of its inflorescence.

[0042] O óleo de girassol compreende ácidos graxos C12 - C22, tais como: ácido láurico, ácido mirístico, ácido palmítico, ácido palmitoleico, ácido esteárico, ácido oleico (Ômega 9), ácido linoleico (Ômega 6), ácido linolênico (Ômega 3), ácido araquídico, ácido eicosenoico, ácido behênico, ácido erúcico e ácido lignocérico, conforme indicando na Tabela 2 abaixo:

Figure imgf000007_0002
Figure imgf000008_0001
[0042] Sunflower oil comprises C12 - C22 fatty acids such as: lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid (Omega 9), linoleic acid (Omega 6), linolenic acid (Omega 3), arachidic acid, eicosenoic acid, behenic acid, erucic acid and lignoceric acid, as indicated in Table 2 below:
Figure imgf000007_0002
Figure imgf000008_0001

TABELA 2 TABLE 2

[0043] Como todos os óleos vegetais, o óleo de girassol é essencialmente constituído por triacilgliceróis (98 a 99%). Tem um elevado teor em ácidos insaturados (cerca de 83%), mas um reduzido teor em ácido linolénico (< 0,2%). O óleo de girassol é essencialmente rico no ácido gordo essencial (AGE) ou ácido linoleico. [0043] Like all vegetable oils, sunflower oil is essentially made up of triacylglycerols (98 to 99%). It has a high content of unsaturated acids (about 83%), but a low content of linolenic acid (< 0.2%). Sunflower oil is essentially rich in essential fatty acid (EFA) or linoleic acid.

[0044] O óleo de girasol segundo a invenção deve apresentar uma acidez Mg KOH/g máxima de 2 medida pelo Método AOCS Ca 5a-40 e compreender cadeia graxa C18: l de 75% a 90,7%. [0044] The sunflower oil according to the invention must have a maximum acidity Mg KOH/g of 2 measured by the AOCS Method Ca 5a-40 and comprise a C18:l grease chain from 75% to 90.7%.

[0045] A composição segundo a invenção compreende em relação a massa total da composição 5% a 22% em massa de lecitina de soja. [0045] The composition according to the invention comprises, in relation to the total mass of the composition, 5% to 22% by mass of soy lecithin.

[0046] A lecitina é um fosfolipídio encontrado de forma natural em alimentos de origem animal e vegetal, sendo a gema de ovo, a soja e o gérmen de trigo as principais fontes. [0046] Lecithin is a phospholipid found naturally in foods of animal and vegetable origin, with egg yolk, soy and wheat germ being the main sources.

[0047] Os principais fosfolípidos presentes na lecitina comercializada (proveniente de soja ou de sementes de girassol) são a fosfatidilcolina, o fosfatidilinositol, o fosfatidiletanolamina e o ácido fosfatídico (geralmente abreviados como PC, PI, PE e PA, respectivamente). De modo a adequar a ação da lecitina de acordo com o produto a que será adicionada, a lecitina poderá ser hidrolizada enzimaticamente. Na lecitina hidrolizada, uma porção dos fosfolípidos têm um ácido gordo removido por ação de uma fosfolipase. Tais fosfolípidos são designados como lisofosfolípidos. A fosfolipase mais usada para este fim é designada como fosfolipase A2, que remove o ácido gordo na posição sn-2. [0047] The main phospholipids present in marketed lecithin (from soy or sunflower seeds) are phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and phosphatidic acid (generally abbreviated as PC, PI, PE and PA, respectively). In order to adapt the action of the lecithin according to the product to which it will be added, the lecithin can be enzymatically hydrolyzed. In hydrolyzed lecithin, a portion of the phospholipids have a fatty acid removed by the action of a phospholipase. Such phospholipids are referred to as lysophospholipids. The most commonly used phospholipase for this purpose is called phospholipase A2, which removes the fatty acid at the sn-2 position.

[0048] As lecitinas podem também ser modificadas por um processo designado como fracionamento, que consiste na mistura do óleo num álcool (geralmente etanol). Alguns fosfolípidos têm boa solubilidade no etanol (por exemplo, a fosfatidilcolina), enquanto que outros fosfolípidos se mostram insolúveis no mesmo solvente. A solução de etanol é, depois, decantada e submetida à evaporação do solvente de modo a obter uma fração de lecitina enriquecida com fosfatidilcolina. [0048] Lecithins can also be modified by a process called fractionation, which consists of mixing the oil in an alcohol (usually ethanol). Some phospholipids have good solubility in ethanol (e.g. phosphatidylcholine), whereas other phospholipids are shown to be insoluble in the same solvent. The ethanol solution is then decanted and subjected to solvent evaporation in order to obtain a phosphatidylcholine-enriched lecithin fraction.

[0049] A lecitina de soja empregada segundo a invenção deve apresentar uma acidez Mg KOH/g de no máximo 2 medida pelo método AOCS Ja 6-55. [0049] The soy lecithin used according to the invention must have an acidity Mg KOH/g of at most 2 measured by the AOCS Ja 6-55 method.

[0050] Segundo uma forma de realização da invenção, a composição compreende em massa em relação à massa total da composição os seguintes componentes: [0050] According to an embodiment of the invention, the composition comprises, by mass in relation to the total mass of the composition, the following components:

(a) de 50% a 85% em peso de óleo de coco; (a) from 50% to 85% by weight of coconut oil;

(b) de 8% a 26% em peso óleo de girassol; e (b) from 8% to 26% by weight sunflower oil; and

(c) de 5% a 22% em peso lecitina de soja. (c) from 5% to 22% by weight soy lecithin.

[0051] Segundo ainda outra forma de realização da invenção, a composição compreende em massa em relação à massa total da composição os seguintes componentes: [0051] According to yet another embodiment of the invention, the composition comprises, by mass in relation to the total mass of the composition, the following components:

(a) de 55% a 80% em peso de óleo de coco; (a) from 55% to 80% by weight of coconut oil;

(b) de 11% a 21% em peso óleo de girassol; e (b) from 11% to 21% by weight sunflower oil; and

(c) de 7% a 15% em peso lecitina de soja. (c) from 7% to 15% by weight soy lecithin.

[0052] A composição substituta de lanolina segundo a invenção apresenta propriedade cicatrizante, podendo ser empregada na indústria farmacêutica em produtos que requeiram esta propriedade como pomadas, emplastros, etc. [0052] The lanolin substitute composition according to the invention has healing properties and can be used in the pharmaceutical industry in products that require this property, such as ointments, plasters, etc.

[0053] O método de obtenção da composição envolve as seguintes etapas: [0053] The method of obtaining the composition involves the following steps:

(a) em um reator são introduzidos de 50% a 85% em massa de óleo de coco e de 8% a 26% em massa de óleo de girassol; (a) 50% to 85% by mass of coconut oil and from 8% to 26% by mass of sunflower oil are introduced into a reactor;

(b) a mistura é aquecida até temperatura entre 40°C e 60°C; (b) the mixture is heated to a temperature between 40°C and 60°C;

(c) ainda mantendo a temperatura entre 40°C e 60°C a mistura é agitada com rotação entre 30 e 50 rpm até a homogeneização; (c) still maintaining the temperature between 40°C and 60°C, the mixture is stirred with rotation between 30 and 50 rpm until homogenization;

(d) em seguida é adicionada de 5% a 22% em massa de lecitina de soja, e a mistura é novamente agitada com rotação entre 30 e 50 rpm, mantendo a temperatura entre 40°C e 60°C até a homogeneização; (d) then 5% to 22% by mass of soy lecithin is added, and the mixture is stirred again with rotation between 30 and 50 rpm, keeping the temperature between 40°C and 60°C until homogenization;

(e) deixa-se o produto obtido esfriar para se proceder com o envase. (e) the product obtained is allowed to cool before filling.

[0054] Segundo outra forma de realização da invenção, o método de obtenção da composição envolve as seguintes etapas: [0054] According to another embodiment of the invention, the method of obtaining the composition involves the following steps:

(a) em um reator são introduzidos de 55% a 80% em massa de óleo de coco e de 11% a 21% em massa de óleo de girassol; (b) a mistura é aquecida até temperatura entre 45 °C e 55 °C; (a) 55% to 80% by mass of coconut oil and from 11% to 21% by mass of sunflower oil are introduced into a reactor; (b) the mixture is heated to a temperature between 45°C and 55°C;

(c) ainda mantendo a temperatura entre 45 °C e 55 °C a mistura é agitada com rotação entre 30 e 50 rpm até a homogeneização; (c) still maintaining the temperature between 45 °C and 55 °C, the mixture is stirred with rotation between 30 and 50 rpm until homogenization;

(d) em seguida é adicionada de 7% a 15% em massa de lecitina de soja, e a mistura é novamente agitada com rotação entre 30 e 50 rpm, mantendo a temperatura entre 45 °C e 55 °C até a homogeneização; (d) then 7% to 15% by mass of soy lecithin is added, and the mixture is stirred again with rotation between 30 and 50 rpm, keeping the temperature between 45 °C and 55 °C until homogenization;

(e) deixa-se o produto obtido esfriar por volta de 35 °C para se proceder com o envase. (e) the product obtained is allowed to cool to around 35°C to proceed with packaging.

[0055] A seguir são apresentados exemplos meramente ilustrativos, que não devem ser tomados para efeito limitativo da invenção. [0055] The following are merely illustrative examples, which should not be taken for the purpose of limiting the invention.

Exemplo 1 Example 1

[0056] Foi reproduzida uma composição substituta de lanolina segundo a invenção compreendendo os componentes conforme indicando na Tabela 3 abaixo:

Figure imgf000010_0001
[0056] A lanolin substitute composition according to the invention was reproduced comprising the components as indicated in Table 3 below:
Figure imgf000010_0001

TABELA 3 TABLE 3

Exemplo 2 Example 2

[0057] A composição indicada no exemplo 1 foi obtida através de protocolo que envolveu as seguintes etapas: [0057] The composition indicated in example 1 was obtained through a protocol that involved the following steps:

- em um reator de inox foram introduzidos primeiramente de 75% em massa de óleo de coco e em seguida de 15% em massa de óleo de girassol; - in a stainless steel reactor, 75% by mass of coconut oil and then 15% by mass of sunflower oil were introduced;

- a mistura foi aquecida até temperatura de 50 °C, até os componentes ficarem líquidos (não aumentou-se mais a temperatura pois as cadeias carbônicas dos componentes podem se quebrar); - the mixture was heated to a temperature of 50 °C, until the components became liquid (the temperature was not increased further as the carbon chains of the components could break);

- com a temperatura mantida de 50 °C os componentes foram misturados com rotação de 35 rpm por 30 minutos até a mistura ficar homogênea; - with the temperature maintained at 50 °C, the components were mixed with a rotation of 35 rpm for 30 minutes until the mixture was homogeneous;

- em seguida foi adicionada lentamente de 10% em massa de lecitina de soja e misturada com rotação de 35 rpm por 40 minutos mantendo-se a temperatura a 50 °C; - a mistura obtida na etapa anterior foi deixada esfriar até 35 °C, pois o envase do produto final deve se dar com o produto no estado líquido. Não é recomendável deixar-se esfriar totalmente, já que o produto pode solidificar no equipamento dificultando assim o envase. - then 10% by mass of soy lecithin was slowly added and mixed with a rotation of 35 rpm for 40 minutes, keeping the temperature at 50 °C; - the mixture obtained in the previous step was allowed to cool to 35 °C, as the final product must be filled with the product in a liquid state. It is not recommended to let it cool completely, as the product can solidify in the equipment, thus making packaging difficult.

Exemplo 3 Example 3

[0058] Com o objetivo de simular uma ferida in vitro, realizou-se um ensaio a partir da monocamada de células. A partir dessa monocamada, foi realizado uma ferida e aplicado o produto-investigacional apresentando a composição indicada no exemplo 1, no meio de cultura suplementado e comparado ao grupo controle. O fechamento da ferida foi acompanhado em diversos períodos de tempo através de imagens para análise da ferida. Esta metodologia mimetizou o processo de cicatrização de feridas in vivo. [0058] With the aim of simulating a wound in vitro, an assay was carried out from the cell monolayer. From this monolayer, a wound was made and the investigational product presenting the composition indicated in example 1 was applied, in the supplemented culture medium and compared to the control group. Wound closure was monitored over different time periods using images for wound analysis. This methodology mimicked the wound healing process in vivo.

[0059] 1. RELEVÂNCIA DO ESTUDO [0059] 1. RELEVANCE OF THE STUDY

[0060] As condições experimentais utilizadas são aceitas e condizentes com as metodologias aplicadas atualmente na comunidade científica internacional, bem como a utilização de células em condições adequadas de cultivo. [0060] The experimental conditions used are accepted and consistent with the methodologies currently applied in the international scientific community, as well as the use of cells under appropriate cultivation conditions.

[0061] 2. METODOLOGIA [0061] 2. METHODOLOGY

[0062] 2.1 Cultura de células [0062] 2.1 Cell culture

[0063] Neste estudo foram utilizadas células de queratinócitos humanos da epiderme, mantidas em cultivo com DMEM (Dulbecco's Modified Eagle's Medium) com adição de suplementos, em estufa a 37°C e 5% de CO2 e manipuladas dentro da capela de fluxo laminar. Na passagem 03 após descongelamento, as células foram distribuídas em placas de 35mm. [0063] In this study, human keratinocyte cells from the epidermis were used, maintained in culture with DMEM (Dulbecco's Modified Eagle's Medium) with the addition of supplements, in an oven at 37°C and 5% CO2 and manipulated inside a laminar flow hood. In passage 03 after thawing, the cells were distributed in 35mm plates.

[0064] 2.2 Preparo da amostra Amostra NV.52.02 [0064] 2.2 Sample preparation Sample NV.52.02

• Condições de preparo da amostra na solução de partida: 10 mg/ml em meio de cultura suplementado. • Sample preparation conditions in the starting solution: 10 mg/ml in supplemented culture medium.

• Aspecto da amostra solubilizada: totalmente solubilizada. • Appearance of the solubilized sample: fully solubilized.

• Concentrações previstas da amostra (mg/ml): lOmg/ ml. • Expected sample concentrations (mg/ml): 10mg/ml.

• Presença de solvente adicional na maior concentração testada da amostra: não se aplica. • Presence of additional solvent at the highest tested concentration of the sample: not applicable.

• Medida de pH na maior concentração testada da amostra: não determinado. • pH measurement at the highest tested concentration of the sample: not determined.

[0065] 2.3 Preparo dos grupos controles Grupo controle: meio de cultura suplementado[0065] 2.3 Preparation of control groups Control group: supplemented culture medium

[0066] 2.4 Realização da ferida e acompanhamento [0067] No momento que as culturas atingiram 100% de confluência, foi realizada uma ferida in vitro e este foi considerado o momento 0h. Neste momento, foi adicionado meio de cultura suplementado no grupo controle e a solução preparada da amostra NV.52.02 para o grupo experimental. As culturas foram mantidas a 37°C por 48 horas, sendo que imagens foram realizadas a cada 15 minutos. [0066] 2.4 Wound realization and follow-up [0067] At the time the cultures reached 100% confluence, an in vitro wound was performed and this was considered the 0h time. At this time, supplemented culture medium was added to the control group and the solution prepared from sample NV.52.02 was added to the experimental group. Cultures were maintained at 37°C for 48 hours, and images were taken every 15 minutes.

[0068] 2.5 Análise dos resultados [0068] 2.5 Analysis of results

[0069] As imagens foram avaliadas com o auxílio do software Image! Foram analisadas as áreas das feridas no tempo 0, 12, 24, 36 e 48 horas para avaliar a porcentagem do fechamento da ferida com o tempo, sendo considerado 0% no momento 0h e considerado 100% de fechamento de ferida quando não era possível observar o fundo da placa. [0069] The images were evaluated with the help of Image! Wound areas were analyzed at 0, 12, 24, 36 and 48 hours to assess the percentage of wound closure over time, with 0% being considered at 0h and 100% wound closure when it was not possible to observe the bottom of the plate.

[0070] 3. RESULTADOS [0070] 3. RESULTS

[0071] As feridas no momento 0h no grupo Controle e grupo Amostra NV.52.02 apresentaram área semelhante. Após 24 horas, observou-se que o grupo Amostra[0071] The wounds at time 0h in the Control group and the Sample NV.52.02 group showed a similar area. After 24 hours, it was observed that the Sample group

NV.52.02 realizou o fechamento da ferida em torno de 81%, enquanto que o grupo controle apresentou fechamento de 53%. Ao final das 36 horas, o grupo AmostraNV.52.02 performed around 81% of wound closure, while the control group had 53% closure. At the end of the 36 hours, the Sample group

NV.12.02 apresentou fechamento completo da ferida simulada, enquanto que o grupo controle precisou de 48 horas para fechar a ferida de maneira completa. NV.12.02 showed complete closure of the sham wound, while the control group needed 48 hours to close the wound completely.

[0072] A Figura 1, em anexo, traz as imagens representativas dos respectivos grupos e tempos. [0072] Figure 1, attached, brings the representative images of the respective groups and times.

[0073] A Figura 2 e a Tabela 4 demonstram a porcentagem de fechamento da ferida conforme o tempo entre os grupos, sendo que foi considerado 0% no tempo 0h e 100% quando não era possível identificar o fundo da placa na imagem.

Figure imgf000012_0001
[0073] Figure 2 and Table 4 demonstrate the percentage of wound closure according to time between groups, with 0% being considered at time 0h and 100% when it was not possible to identify the bottom of the plaque in the image.
Figure imgf000012_0001

TABELA 4 TABLE 4

[0074] 4. CONCLUSÕES [0074] 4. CONCLUSIONS

[0075] De acordo com os resultados obtidos, é possível afirmar que: - A amostra NV.52.02 reduziu o tempo de fechamento total da ferida. [0075] According to the results obtained, it is possible to state that: - The sample NV.52.02 reduced the time of total wound closure.

Exemplo 4 [0076] Foi reproduzida uma composição substituta de lanolina segundo a invenção compreendendo os componentes conforme indicando na Tabela 5 abaixo:

Figure imgf000013_0001
Example 4 [0076] A lanolin substitute composition according to the invention was reproduced comprising the components as indicated in Table 5 below:
Figure imgf000013_0001

TABELA 5 TABLE 5

Claims

Reivindicações claims 1. Composição a base de óleos vegetais substituta de lanolina caracterizada por compreender: 1. Composition based on vegetable oils to replace lanolin characterized by comprising: (f) óleo de coco; (f) coconut oil; (g)óleo de girassol; e (g) sunflower oil; and (h) lecitina de soja. (h) soy lecithin. 2. Composição a base de óleos vegetais substituta de lanolina, de acordo com a reivindicação 1, caracterizada por compreender: 2. Composition based on vegetable oils replacing lanolin, according to claim 1, characterized in that it comprises: (a) de 50% a 85% em peso de óleo de coco; (a) from 50% to 85% by weight of coconut oil; (b) de 8% a 26% em peso óleo de girassol; e (b) from 8% to 26% by weight sunflower oil; and (c) de 5% a 22% em peso lecitina de soja. (c) from 5% to 22% by weight soy lecithin. 3. Composição a base de óleos vegetais substituta de lanolina, de acordo com a reivindicação 1 ou 2, caracterizada por 3. Composition based on vegetable oil substitutes for lanolin, according to claim 1 or 2, characterized in that (a) de 55% a 80% em peso de óleo de coco; (a) from 55% to 80% by weight of coconut oil; (b) de 11% a 21% em peso óleo de girassol; e (b) from 11% to 21% by weight sunflower oil; and (c) de 7% a 15% em peso lecitina de soja. (c) from 7% to 15% by weight soy lecithin. 4. Composição a base de óleos vegetais substituta de lanolina, de acordo com as reivindicações 1 a 3, caracterizada por o óleo de coco ser refinado e apresentar uma acidez Mg KOH/g máxima de 0,1 % medida pelo Método AOCS Ca 5a-40.4. Composition based on vegetable oil substitutes for lanolin, according to claims 1 to 3, characterized in that the coconut oil is refined and has a maximum acidity Mg KOH/g of 0.1% measured by the AOCS Method Ca 5a- 40. 5. Composição a base de óleos vegetais substituta de lanolina, de acordo com as reivindicações 1 a 3, caracterizada por o óleo de girasol apresenta uma acidez Mg KOH/g máxima de 2 medida pelo Método AOCS Ca 5a-40 e deve compreender uma cadeia graxa C18: l de 75% a 90,7%. Composition based on vegetable oils replacing lanolin, according to claims 1 to 3, characterized in that the sunflower oil has a maximum acidity Mg KOH/g of 2 measured by the AOCS Method Ca 5a-40 and must comprise a chain C18 grease: l from 75% to 90.7%. 6. Composição a base de óleos vegetais substituta de lanolina, de acordo com as reivindicações 1 a 3, caracterizada por a lecitina de soja apresentar uma acidez Mg KOH/g de no máximo 2 medida pelo método AOCS Ja 6-55. 6. Composition based on vegetable oils replacing lanolin, according to claims 1 to 3, characterized in that the soy lecithin has an acidity Mg KOH/g of at most 2 measured by the AOCS Ja 6-55 method. 7. Método de obtenção de composição a base de óleos vegetais substituta de lanolina conforme reivindicação 1, caracterizado por apresentar as seguintes etapas: 7. Method of obtaining a composition based on vegetable oils to replace lanolin according to claim 1, characterized in that it has the following steps: (a) num reator são introduzidos de 50% a 85% em massa de óleo de coco e de 8% a 26% em massa de óleo de girassol; (b) a mistura é aquecida até temperatura entre 40°C e 60°C; (a) 50% to 85% by mass of coconut oil and from 8% to 26% by mass of sunflower oil are introduced into a reactor; (b) the mixture is heated to a temperature between 40°C and 60°C; (c) ainda mantendo a temperatura entre 40°C e 60°C a mistura é agitada com rotação entre 30 e 50 rpm até a homegeinização; (c) still maintaining the temperature between 40°C and 60°C, the mixture is stirred with rotation between 30 and 50 rpm until homogenization; (d) em seguida é adicionada de 5% a 22% em massa de lecitina de soja, e a mistura é novamente agitada com rotação entre 30 e 50 rpm, mantendo a temperatura entre 40°C e 60°C até a homogeinização; (d) then 5% to 22% by mass of soy lecithin is added, and the mixture is stirred again with rotation between 30 and 50 rpm, keeping the temperature between 40°C and 60°C until homogenization; (e) deixa-se o produto obtido esfriar para se proceder com o envase. (e) the product obtained is allowed to cool before filling. 10. Método de obtenção de composição a base de óleos vegetais substituta de lanolina conforme reivindicação 9, caracterizado por apresentar as seguintes etapas: 10. Method of obtaining a composition based on vegetable oils to replace lanolin according to claim 9, characterized in that it has the following steps: (a) em um reator são introduzidos de 55% a 80% em massa de óleo de coco e de 11% a 21% em massa de óleo de girassol; (a) 55% to 80% by mass of coconut oil and from 11% to 21% by mass of sunflower oil are introduced into a reactor; (b) a mistura é aquecida até temperatura entre 45°C e 55 °C; (b) the mixture is heated to a temperature between 45°C and 55°C; (c) ainda mantendo a temperatura entre 45 °C e 55 °C a mistura é agitada com rotação entre 30 e 50 rpm até a homegeinização; (c) still maintaining the temperature between 45 °C and 55 °C, the mixture is stirred with rotation between 30 and 50 rpm until homogenization; (d) em seguida é adicionada de 7% a 15% em massa de lecitina de soja, e a mistura é novamente agitada com rotação entre 30 e 50 rpm, mantendo a temperatura entre 45 °C e 55 °C até a homogeinização; (d) then 7% to 15% by mass of soy lecithin is added, and the mixture is stirred again with rotation between 30 and 50 rpm, keeping the temperature between 45 °C and 55 °C until homogenization; (e) deixa-se o produto obtido esfriar por volta de 35 °C para se proceder com o envase. (e) the product obtained is allowed to cool to around 35°C to proceed with packaging.
PCT/BR2020/050313 2020-08-11 2020-08-11 Composition based on plant oils to replace lanolin Ceased WO2022032360A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/BR2020/050313 WO2022032360A1 (en) 2020-08-11 2020-08-11 Composition based on plant oils to replace lanolin
BR112023002610A BR112023002610A2 (en) 2020-08-11 2020-08-11 ADDITIVE COMPOSITION BASED ON VEGETABLE OILS SUBSTITUTING LANOLIN AND OBTAINING METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2020/050313 WO2022032360A1 (en) 2020-08-11 2020-08-11 Composition based on plant oils to replace lanolin

Publications (1)

Publication Number Publication Date
WO2022032360A1 true WO2022032360A1 (en) 2022-02-17

Family

ID=80246618

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2020/050313 Ceased WO2022032360A1 (en) 2020-08-11 2020-08-11 Composition based on plant oils to replace lanolin

Country Status (2)

Country Link
BR (1) BR112023002610A2 (en)
WO (1) WO2022032360A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161484A1 (en) * 2002-04-19 2004-08-19 Dee Gary J. Vegetable substitute for lanolin
US20050233015A1 (en) * 2002-05-27 2005-10-20 Staffan Norberg Lanolin substitute based on shea butter
WO2008150603A1 (en) * 2007-06-01 2008-12-11 Elc Management Llc Well preserved aqueous organic compositions
US20130224138A1 (en) * 2001-07-02 2013-08-29 Pierre Charlier De Chily Lanolin substitute, production method thereof and applications of same
US20190380350A1 (en) * 2016-01-21 2019-12-19 Penta 5 USA, LLC Topical mosquito control product with sunscreen
US20200171119A1 (en) * 2017-05-24 2020-06-04 Rachel Sarah Levine Composition for transdermal delivery of glutathione

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130224138A1 (en) * 2001-07-02 2013-08-29 Pierre Charlier De Chily Lanolin substitute, production method thereof and applications of same
US20040161484A1 (en) * 2002-04-19 2004-08-19 Dee Gary J. Vegetable substitute for lanolin
US20050233015A1 (en) * 2002-05-27 2005-10-20 Staffan Norberg Lanolin substitute based on shea butter
WO2008150603A1 (en) * 2007-06-01 2008-12-11 Elc Management Llc Well preserved aqueous organic compositions
US20190380350A1 (en) * 2016-01-21 2019-12-19 Penta 5 USA, LLC Topical mosquito control product with sunscreen
US20200171119A1 (en) * 2017-05-24 2020-06-04 Rachel Sarah Levine Composition for transdermal delivery of glutathione

Also Published As

Publication number Publication date
BR112023002610A2 (en) 2023-04-04

Similar Documents

Publication Publication Date Title
Mititelu et al. Neacs, u
ES2864285T3 (en) Using whole soft avocados to obtain an avocado oil rich in unsaponifiability
KR101121949B1 (en) Composition and manufacturing method of steam cream for enhancing moisture content
JP3502990B2 (en) Method for separating compounds containing plant-derived glycolipid, lysophospholipid, sphingolipid, ceramide
US8765105B2 (en) Human sebum mimetics derived from botanical sources and methods for making the same
CN109806177A (en) A kind of high-efficiency moisturizing composition
ES2864594T3 (en) Use of avocado pit to obtain avocado oil enriched in alkyl polyols and / or their acetylated derivatives
ITMI20072081A1 (en) GLYCEROL ESTERS AND THEIR EMPLOYMENT IN COSMETIC AND PHARMACEUTICAL SCOPE
Gutierrez et al. Cottonseed oil composition and its application to skin health and personal care
WO2022032360A1 (en) Composition based on plant oils to replace lanolin
Shahbaz et al. Beeswax
ES2864598T3 (en) Use of avocado skin to obtain an unsaponifiable avocado enriched in saturated aliphatic hydrocarbons and sterols
US20140105844A1 (en) Human sebum mimetics derived from botanical sources and methods for making the same
KR100826310B1 (en) Cosmetic composition
CA2884331C (en) Human sebum mimetics derived from botanical sources and methods for making the same
JP2014516940A (en) Highly unsaponifiable matter and method of using the same
US8765106B2 (en) Human sebum mimetics derived from botanical sources and methods for making the same
CN108542807A (en) A kind of production method with moisturizing and crease-resistant hand lotion
US20150004139A1 (en) Emollient Compounds Useful for Treating Dry Skin Conditions
da Costa Sanches et al. The use of vegetable oils to prevent skin aging
Krishna Coconut oil: science, technology, and applications
BR102017028213B1 (en) COSMETIC COMPOSITION INCLUDES LICURI OIL, USE OF SUCH COMPOSITION AND COSMETIC METHOD
Shahbaz et al. 10 Beeswax
CA2932042C (en) Human sebum mimetics derived from botanical sources and methods for making the same
JP2007008911A (en) Cosmetics

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20948899

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112023002610

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 112023002610

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20230210

122 Ep: pct application non-entry in european phase

Ref document number: 20948899

Country of ref document: EP

Kind code of ref document: A1